Teligent (TLGT) Reports Q3 EPS of $0.01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St ends higher on cool inflation data, strong earnings
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices make small gain on smaller US inventory draw
- ASML capacity upgrade soothes AI chip bottleneck fears
Teligent, Inc. Announces Third Quarter 2016 Results
October 27, 2016 4:02 PM EDTBUENA, N.J., Oct. 27, 2016 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2016.
Third Quarter 2016 Highlights
Total revenues of $16.2 million in the third quarter of 2016, an increase of 39% over the same quarter in 2015. Total net revenues generated from the sale of our generic topical and injectable... More